Press "Enter" to skip to content

Booster Dose of the Vaccination Boosts Antibody Levels according to J&J

As of yesterday, the firm stated it has submitted them for publishing to the preprint platform medRxiv. This Booster shot increased antibody levels ninefold compared to 28 days after the single-dose injection of the vaccine, which was approved by U.S. authorities in February.

For the company’s study, two short studies were conducted. There were just 17 volunteers, while on the other there were 79. According to the report, the Booster dose was given six months after the initial J&J shot.After 8 months of receiving a second dose of a mRNA (messenger RNA) vaccine, recipients of the Pfizer and Moderna vaccines would be eligible for Booster, the Biden administration said last week. A single-dose J&J vaccine, the only one in the United States authorized for single-dose use was left out of the plan.

An adenovirus instead of an mRNA vaccination is used to transmit the gene that tells cells how to make the spike protein that coats the pandemic coronavirus. Other than for the immunocompromised, the U.S. Food and Drug Administration haven’t approved any Booster plans yet (FDA).

Global head of R&D at Janssen Pharmaceuticals Mathai Mammen said that J&J currently expects to be included in any U.S. Booster plan In the near future, public health experts will explore a potential method for our Johnson & Johnson COVID-19 vaccine, including boosting eight months or longer after the original single-dose vaccination.Director of the FDA’s vaccine approval division Peter Marks tells ScienceInsider that the government will evaluate J&J’s latest vaccine-approval data.

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *